speed
compensation
stock option
scope of work
science
Kontras
no good sop
internal politics
unclear decision
low cost efficacy
Mehr Bewertungen zu BeOne entdecken
5.0
24. Apr. 2026
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.
Kontras
Fast timelines and global expansion may translate into heavy workload and urgency